Tacrolimus (Kidney transplant maintenance immunosuppression)

DRUG2 trials

Sponsors

Imperial College Healthcare NHS Trust, Virginia Commonwealth University

Conditions

End-stage Renal FailureGraft RejectionKidney Transplant Recipient

Early Phase 1

Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients

Not yet recruitingNCT07806136

Virginia Commonwealth UniversityKidney Transplant Recipient

Start: 2026-08-31End: 2029-08-01Target: 20Updated: 2026-09-08

Phase 4

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

CompletedNCT00807144

Imperial College Healthcare NHS TrustEnd-stage Renal Failure, Graft Rejection

Start: 2008-12-31End: 2012-03-31Updated: 2021-08-27